SlideShare ist ein Scribd-Unternehmen logo
1 von 26
Downloaden Sie, um offline zu lesen
BY, MS. PRIYANKA GOHIL
MSc (N) OBG, PhD SCHOLAR
MBNC,UTU
Maternal drug intake during nursing may have adverse effect
not only on lactation but also on the baby through the ingested
breast milk.
Any drug ingested by a nursing mother may be present in her
breast milk, but its concentration are usually low compared to
blood levels in the mother.
Usually such low levels are not of any clinical significance to
the infant.
However, milk concentration of some drugs may exceed those
in the maternal plasma so that therapeutic doses in the mother
may cause toxicity to the infant.
Common side effects from maternal medication on breastfed
infants are....
Diarrhoea (antibiotics)
irritability (antihistaminics)
Drowsiness (sedatives, antidepressants, antiepileptics)
Benefits of breastfeeding are well known.
The risk of drug exposure to the neonate must be weighed
against these benefits.
If the drug amount is 1 to 2 % of the mother, usually no
adverse effects are noted.
Factors involved in drug transfer into milk
Chemical properties of the drug
Molecular wright
Degree of protein biding
Ionic dilocation
Lipid solubility
Tissue pH
Drug concentration in maternal blood
Duration of exposure time
Guidelines for medication during lactation
Benefits of medication must outweigh the risks
Select drugs that are most widely tested and with short half
life
Monitor the infant during the course of therapy
Non- ionized, low molecular weight, lipid soluble
compounds are usually excreted through breast milk.
Maternal drug intake and breastfeeding
Maternal drug intake and breastfeeding
Teratology and prescribing in pregnancy:
Teratogen causes permanent alteration in the structure and/or
function of an organ, acting during the embryonic or fetal life.
The teratogens may be chemical agents (drugs) or physical
agents (radiation, heat).
The dose (amount) and duration of teratogen exposure may
cause variable response from no effect level to lethal level.
Final results of an abnormal development are: death,
malformation, growth restriction and functional disorder.
The term ‘placental barrier’ is a contradiction.
Virtually drugs cross the barrier with the exception of few with
large organic ions such as heparin and insulin.
 Approximately 25% of human development defects are genetic
in origin, 2–3% are due to drug exposure and about 65% are
either unknown or from combination of genetic and
environmental factors.
Mechanism of Teratology
The actual mechanism is unknown. Teratogens may affect
through the following ways:
1. Folic acid deficiency
2. Epoxides or arena oxides
3. Environments and genes
4. Maternal disease and drugs
5. Homeobox genes
1. Folic acid deficiency:-
It leads to deficient methionine production and RNA, DNA
synthesis.
Folic acid is essential for normal meiosis and mitosis.
 Periconceptional folate deficiency leads to neural tube defects,
cleft lips and palate
2. Epoxides or arena oxides:-
These are the oxidative inter metabolites of many drugs like
hydantoin and carbamazepine.
These intermediary metabolites have carcinogenic and
teratogenic effects unless they are detoxified by fetal epoxide
hydrolase.
3. Environment and Genes:-
Abnormalities that are multifactorial depend on the ultimate
interaction between the environment and fetal gene mutation.
Genotype of the embryo and their susceptibility to teratogens
(valproic acid) are the important determinants.
Embryonic period (2nd–8th weeks) is most vulnerable.
Homozygous gene mutations are associated with more
anomalies.
4. Maternal disease and drugs:-
 Maternal disease and drugs (epilepsy and anticonvulsants)
have an increased risk of fetal anomalies.
Paternal exposure to drugs or mutagens (polycyclic
hydrocarbons) can cause gene mutation and chromosomal
abnormality in sperm.
5. Homeobox genes:-
 Homeobox genes are groups of regulatory genes that control
the expression of other genes involved in the normal
development of growth and diff erentiation.
Teratogens like retinoic acid can dysregulate these genes to
cause abnormal gene expression.
Timing of Teratogen exposure and the hazards:
Before D 31:
Teratogen produces an all or none effect.
The conceptus either does not survive or survives without
anomalies.
In early conception only few cells are there.
So any damage at that phase is irreparable and is lethal.
D 31-D 71:
D 31-D 71 is the critical period for organ formation.
Effects of teratogen depend on the following factors:
(i) Amount of the drug reaching the fetus,
(ii) Gestational age at the time of exposure,
(iii) Duration of exposure.
After D 71:
After D 71 development of other organs continues.
Diethylstilbestrol (DES) related uterine anomalies occur with
exposure around 20 weeks.
Brain continues to develop throughout pregnancy and
neonatal period.
Fetal alcohol syndrome occurs in late pregnancy.
Maternal drug intake and breastfeeding
Placental transfer of drugs:
Most drugs cross the placental barrier by simple diffusion. The
factors responsible for transfer are:
a. Molecular weight (molecular weight > 1,000 Da do not
cross the placenta)
b. Protein binding
c. Concentration of free drug
d. Lipid solubility
e. Degree of ionization tissue pH
f. Uteroplacental blood flow
g. Placental surface area.
 The rate of drug transfer across the placenta is increased in
late pregnancy.
This is due to:
a. Increased unbound drug available for transfer
b. Increased uteroplacental blood flow
c. Increased placental surface area
d. Decreased thickness of the placental membranes
Maternal drug intake and breastfeeding
Keeping these in mind, the following guidelines are
formulated:
If the benefit outweighs the potential risks, only then can the
particular drug be used with prior counseling
Only, well tested and reputed drugs are to be prescribed and
that too using the minimum therapeutic dosage for the shortest
possible duration.
ALCOHOl:
Heavy drinkers (≥ 3 oz) have major risk to the fetus (6%).
Fetal Alcohol Syndrome (FAS) is defined as the presence of at
least one characteristic from each of the following three
categories:
1. Growth restriction before and/or after birth.
2. Facial anomalies: Small palpebral fi ssures, indistinct or
absent philtrum, epicanthic folds, fl attened nasal bridge,
short length of nose, thin upper lip, low set and unparallel
ears and retarded midfacial development.
3. CNS dysfunction: Microcephaly, mental retardation, abnormal
neurobehavioral development (attention deficit with
hyperactivity).
PATERNALLY MEDICATED DRUGS AFFECTING HUMAN
PREGNANCY:
Adverse effects on human progeny has been observed in the
form of abortion, congenital malformations, low birth weight and
increased perinatal loss when the father has been exposed to
lead, anesthetic agents, smoking or caffeine ingestion.
These agents probably alter the morphology of the spermatozoa
or cause some change in the composition of the semen.
Maternal drug intake and breastfeeding

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

TOCOLYTIC AGENT.pptx
TOCOLYTIC AGENT.pptxTOCOLYTIC AGENT.pptx
TOCOLYTIC AGENT.pptx
 
Cord Prolapse
Cord ProlapseCord Prolapse
Cord Prolapse
 
Drugs used in pregnancy, labour and puerperium
Drugs used in pregnancy, labour and puerperiumDrugs used in pregnancy, labour and puerperium
Drugs used in pregnancy, labour and puerperium
 
Screening of high risk pregnancy
Screening of high risk pregnancyScreening of high risk pregnancy
Screening of high risk pregnancy
 
Pharmacotherapeutics in obstetrics
Pharmacotherapeutics in obstetricsPharmacotherapeutics in obstetrics
Pharmacotherapeutics in obstetrics
 
Post natal care update
Post natal care updatePost natal care update
Post natal care update
 
HIV In Pregnancy
HIV In Pregnancy HIV In Pregnancy
HIV In Pregnancy
 
Post partum hemorrhage obs and gyne
Post partum hemorrhage obs and gynePost partum hemorrhage obs and gyne
Post partum hemorrhage obs and gyne
 
Induction of labor
Induction of laborInduction of labor
Induction of labor
 
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOURNURSING MANAGEMENT OF SECOND STAGE OF LABOUR
NURSING MANAGEMENT OF SECOND STAGE OF LABOUR
 
MTP
MTPMTP
MTP
 
Oxytocics and tocolytics
Oxytocics and tocolyticsOxytocics and tocolytics
Oxytocics and tocolytics
 
Placenta examination
Placenta examinationPlacenta examination
Placenta examination
 
Immediate care for the new borns
Immediate care for the new bornsImmediate care for the new borns
Immediate care for the new borns
 
Drugs in obstetrics
Drugs in obstetricsDrugs in obstetrics
Drugs in obstetrics
 
Analgesics and anestheia
Analgesics and anestheiaAnalgesics and anestheia
Analgesics and anestheia
 
Placenta previa
Placenta previaPlacenta previa
Placenta previa
 
Psychiatric disorders in pregnancy
Psychiatric disorders in pregnancy Psychiatric disorders in pregnancy
Psychiatric disorders in pregnancy
 
Drugs and pregnancy
Drugs and pregnancyDrugs and pregnancy
Drugs and pregnancy
 
breech presentation
breech presentationbreech presentation
breech presentation
 

Ähnlich wie Maternal drug intake and breastfeeding

Drugs in pregnancy
Drugs in pregnancyDrugs in pregnancy
Drugs in pregnancyredbaron_ad
 
Drugs use in pregnancy
Drugs use in pregnancyDrugs use in pregnancy
Drugs use in pregnancyVikas Sharma
 
Issues to consider while prescribing for pregnant and lactating patients
Issues to consider while prescribing for pregnant and lactating patientsIssues to consider while prescribing for pregnant and lactating patients
Issues to consider while prescribing for pregnant and lactating patientssamthamby79
 
Teratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyTeratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyabhishekbharti51
 
Repro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdfRepro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdfSanjayaManiDixit
 
Teratogenicity and the drugs causing it
Teratogenicity and the drugs causing itTeratogenicity and the drugs causing it
Teratogenicity and the drugs causing itTheDReamer3
 
Drug uses in special physiology( pregnancy , lactation, infant , children, ge...
Drug uses in special physiology( pregnancy , lactation, infant , children, ge...Drug uses in special physiology( pregnancy , lactation, infant , children, ge...
Drug uses in special physiology( pregnancy , lactation, infant , children, ge...Akshil Mehta
 
<마더리스크라운드>Practical counselling of major human teratogens
<마더리스크라운드>Practical counselling of major human teratogens<마더리스크라운드>Practical counselling of major human teratogens
<마더리스크라운드>Practical counselling of major human teratogensmothersafe
 
Teratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyTeratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyabhishekbharti51
 
Drugs used in pregnancy
Drugs used in pregnancyDrugs used in pregnancy
Drugs used in pregnancyethan1hunt
 
Drug Prescribing in Pregnancy.pptx
Drug Prescribing in Pregnancy.pptxDrug Prescribing in Pregnancy.pptx
Drug Prescribing in Pregnancy.pptxindiarto1
 
drugs in pregnancy
 drugs in pregnancy drugs in pregnancy
drugs in pregnancymt53y8
 
7 drugs in pregnancy2010
7 drugs in pregnancy20107 drugs in pregnancy2010
7 drugs in pregnancy2010obsgyna
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)drmcbansal
 
(마더리스크라운드) 기형학의 원칙
(마더리스크라운드) 기형학의 원칙(마더리스크라운드) 기형학의 원칙
(마더리스크라운드) 기형학의 원칙mothersafe
 
Prescribing in pregnancy
Prescribing in pregnancyPrescribing in pregnancy
Prescribing in pregnancyYogesh Patel
 
Drug therapy in Pediatrics & Gerontology
Drug therapy in Pediatrics & GerontologyDrug therapy in Pediatrics & Gerontology
Drug therapy in Pediatrics & GerontologyEneutron
 

Ähnlich wie Maternal drug intake and breastfeeding (20)

Drugs in pregnancy
Drugs in pregnancyDrugs in pregnancy
Drugs in pregnancy
 
8. Teratology.pptx
8. Teratology.pptx8. Teratology.pptx
8. Teratology.pptx
 
Drugs use in pregnancy
Drugs use in pregnancyDrugs use in pregnancy
Drugs use in pregnancy
 
Issues to consider while prescribing for pregnant and lactating patients
Issues to consider while prescribing for pregnant and lactating patientsIssues to consider while prescribing for pregnant and lactating patients
Issues to consider while prescribing for pregnant and lactating patients
 
Teratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyTeratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancy
 
Repro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdfRepro-Drugs_in_Pregnancy.pdf
Repro-Drugs_in_Pregnancy.pdf
 
Teratogenicity and the drugs causing it
Teratogenicity and the drugs causing itTeratogenicity and the drugs causing it
Teratogenicity and the drugs causing it
 
Drug uses in special physiology( pregnancy , lactation, infant , children, ge...
Drug uses in special physiology( pregnancy , lactation, infant , children, ge...Drug uses in special physiology( pregnancy , lactation, infant , children, ge...
Drug uses in special physiology( pregnancy , lactation, infant , children, ge...
 
<마더리스크라운드>Practical counselling of major human teratogens
<마더리스크라운드>Practical counselling of major human teratogens<마더리스크라운드>Practical counselling of major human teratogens
<마더리스크라운드>Practical counselling of major human teratogens
 
Teratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancyTeratogenecity & Safety of drugs in pregnancy
Teratogenecity & Safety of drugs in pregnancy
 
Drugs used in pregnancy
Drugs used in pregnancyDrugs used in pregnancy
Drugs used in pregnancy
 
Drug Prescribing in Pregnancy.pptx
Drug Prescribing in Pregnancy.pptxDrug Prescribing in Pregnancy.pptx
Drug Prescribing in Pregnancy.pptx
 
drugs in pregnancy
 drugs in pregnancy drugs in pregnancy
drugs in pregnancy
 
7 drugs in pregnancy2010
7 drugs in pregnancy20107 drugs in pregnancy2010
7 drugs in pregnancy2010
 
seminar on maternal drugs
seminar on maternal  drugsseminar on maternal  drugs
seminar on maternal drugs
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)
 
(마더리스크라운드) 기형학의 원칙
(마더리스크라운드) 기형학의 원칙(마더리스크라운드) 기형학의 원칙
(마더리스크라운드) 기형학의 원칙
 
Prescribing in pregnancy
Prescribing in pregnancyPrescribing in pregnancy
Prescribing in pregnancy
 
Drug therapy in Pediatrics & Gerontology
Drug therapy in Pediatrics & GerontologyDrug therapy in Pediatrics & Gerontology
Drug therapy in Pediatrics & Gerontology
 
Teratogenesis
TeratogenesisTeratogenesis
Teratogenesis
 

Mehr von Priyanka Gohil

Fundamentals of reproduction
Fundamentals of reproductionFundamentals of reproduction
Fundamentals of reproductionPriyanka Gohil
 
Physiology of menstrual cycle
Physiology of menstrual cyclePhysiology of menstrual cycle
Physiology of menstrual cyclePriyanka Gohil
 
Physical & chemical structure of matter
Physical & chemical structure of matterPhysical & chemical structure of matter
Physical & chemical structure of matterPriyanka Gohil
 
Organization of matter important terms
Organization of matter  important termsOrganization of matter  important terms
Organization of matter important termsPriyanka Gohil
 
Vital statistics related to maternal health in india
Vital statistics related to maternal health in indiaVital statistics related to maternal health in india
Vital statistics related to maternal health in indiaPriyanka Gohil
 
Introduction to midwifery
Introduction to midwiferyIntroduction to midwifery
Introduction to midwiferyPriyanka Gohil
 
Ventouse or vaccum delivery
Ventouse or vaccum deliveryVentouse or vaccum delivery
Ventouse or vaccum deliveryPriyanka Gohil
 
Genital prolapse in pregnancy
Genital prolapse in pregnancyGenital prolapse in pregnancy
Genital prolapse in pregnancyPriyanka Gohil
 
Inversion of the uterus
Inversion of the uterusInversion of the uterus
Inversion of the uterusPriyanka Gohil
 
Amniotic fluid embolism
Amniotic fluid embolismAmniotic fluid embolism
Amniotic fluid embolismPriyanka Gohil
 
Problem based learning
Problem based learningProblem based learning
Problem based learningPriyanka Gohil
 

Mehr von Priyanka Gohil (20)

Fundamentals of reproduction
Fundamentals of reproductionFundamentals of reproduction
Fundamentals of reproduction
 
Physiology of menstrual cycle
Physiology of menstrual cyclePhysiology of menstrual cycle
Physiology of menstrual cycle
 
Female pelvis
Female pelvisFemale pelvis
Female pelvis
 
Physical & chemical structure of matter
Physical & chemical structure of matterPhysical & chemical structure of matter
Physical & chemical structure of matter
 
Organization of matter important terms
Organization of matter  important termsOrganization of matter  important terms
Organization of matter important terms
 
Vital statistics related to maternal health in india
Vital statistics related to maternal health in indiaVital statistics related to maternal health in india
Vital statistics related to maternal health in india
 
Introduction to midwifery
Introduction to midwiferyIntroduction to midwifery
Introduction to midwifery
 
Ventouse or vaccum delivery
Ventouse or vaccum deliveryVentouse or vaccum delivery
Ventouse or vaccum delivery
 
Genital prolapse in pregnancy
Genital prolapse in pregnancyGenital prolapse in pregnancy
Genital prolapse in pregnancy
 
Inversion of the uterus
Inversion of the uterusInversion of the uterus
Inversion of the uterus
 
Vasa previa
Vasa previaVasa previa
Vasa previa
 
Amniotic fluid embolism
Amniotic fluid embolismAmniotic fluid embolism
Amniotic fluid embolism
 
Normal puerperium
Normal puerperiumNormal puerperium
Normal puerperium
 
Normal labour
Normal labourNormal labour
Normal labour
 
Unstable lie
Unstable lieUnstable lie
Unstable lie
 
Antenatal assessment
Antenatal assessment  Antenatal assessment
Antenatal assessment
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
 
Obstetrical shock
Obstetrical shockObstetrical shock
Obstetrical shock
 
Problem based learning
Problem based learningProblem based learning
Problem based learning
 
Cord prolapse
Cord prolapseCord prolapse
Cord prolapse
 

Kürzlich hochgeladen

ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 

Kürzlich hochgeladen (20)

American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 

Maternal drug intake and breastfeeding

  • 1. BY, MS. PRIYANKA GOHIL MSc (N) OBG, PhD SCHOLAR MBNC,UTU
  • 2. Maternal drug intake during nursing may have adverse effect not only on lactation but also on the baby through the ingested breast milk. Any drug ingested by a nursing mother may be present in her breast milk, but its concentration are usually low compared to blood levels in the mother. Usually such low levels are not of any clinical significance to the infant. However, milk concentration of some drugs may exceed those in the maternal plasma so that therapeutic doses in the mother may cause toxicity to the infant.
  • 3. Common side effects from maternal medication on breastfed infants are.... Diarrhoea (antibiotics) irritability (antihistaminics) Drowsiness (sedatives, antidepressants, antiepileptics) Benefits of breastfeeding are well known. The risk of drug exposure to the neonate must be weighed against these benefits. If the drug amount is 1 to 2 % of the mother, usually no adverse effects are noted.
  • 4. Factors involved in drug transfer into milk Chemical properties of the drug Molecular wright Degree of protein biding Ionic dilocation Lipid solubility Tissue pH Drug concentration in maternal blood Duration of exposure time
  • 5. Guidelines for medication during lactation Benefits of medication must outweigh the risks Select drugs that are most widely tested and with short half life Monitor the infant during the course of therapy Non- ionized, low molecular weight, lipid soluble compounds are usually excreted through breast milk.
  • 8. Teratology and prescribing in pregnancy: Teratogen causes permanent alteration in the structure and/or function of an organ, acting during the embryonic or fetal life. The teratogens may be chemical agents (drugs) or physical agents (radiation, heat). The dose (amount) and duration of teratogen exposure may cause variable response from no effect level to lethal level. Final results of an abnormal development are: death, malformation, growth restriction and functional disorder.
  • 9. The term ‘placental barrier’ is a contradiction. Virtually drugs cross the barrier with the exception of few with large organic ions such as heparin and insulin.  Approximately 25% of human development defects are genetic in origin, 2–3% are due to drug exposure and about 65% are either unknown or from combination of genetic and environmental factors.
  • 10. Mechanism of Teratology The actual mechanism is unknown. Teratogens may affect through the following ways: 1. Folic acid deficiency 2. Epoxides or arena oxides 3. Environments and genes 4. Maternal disease and drugs 5. Homeobox genes
  • 11. 1. Folic acid deficiency:- It leads to deficient methionine production and RNA, DNA synthesis. Folic acid is essential for normal meiosis and mitosis.  Periconceptional folate deficiency leads to neural tube defects, cleft lips and palate
  • 12. 2. Epoxides or arena oxides:- These are the oxidative inter metabolites of many drugs like hydantoin and carbamazepine. These intermediary metabolites have carcinogenic and teratogenic effects unless they are detoxified by fetal epoxide hydrolase.
  • 13. 3. Environment and Genes:- Abnormalities that are multifactorial depend on the ultimate interaction between the environment and fetal gene mutation. Genotype of the embryo and their susceptibility to teratogens (valproic acid) are the important determinants. Embryonic period (2nd–8th weeks) is most vulnerable. Homozygous gene mutations are associated with more anomalies.
  • 14. 4. Maternal disease and drugs:-  Maternal disease and drugs (epilepsy and anticonvulsants) have an increased risk of fetal anomalies. Paternal exposure to drugs or mutagens (polycyclic hydrocarbons) can cause gene mutation and chromosomal abnormality in sperm.
  • 15. 5. Homeobox genes:-  Homeobox genes are groups of regulatory genes that control the expression of other genes involved in the normal development of growth and diff erentiation. Teratogens like retinoic acid can dysregulate these genes to cause abnormal gene expression.
  • 16. Timing of Teratogen exposure and the hazards: Before D 31: Teratogen produces an all or none effect. The conceptus either does not survive or survives without anomalies. In early conception only few cells are there. So any damage at that phase is irreparable and is lethal.
  • 17. D 31-D 71: D 31-D 71 is the critical period for organ formation. Effects of teratogen depend on the following factors: (i) Amount of the drug reaching the fetus, (ii) Gestational age at the time of exposure, (iii) Duration of exposure.
  • 18. After D 71: After D 71 development of other organs continues. Diethylstilbestrol (DES) related uterine anomalies occur with exposure around 20 weeks. Brain continues to develop throughout pregnancy and neonatal period. Fetal alcohol syndrome occurs in late pregnancy.
  • 20. Placental transfer of drugs: Most drugs cross the placental barrier by simple diffusion. The factors responsible for transfer are: a. Molecular weight (molecular weight > 1,000 Da do not cross the placenta) b. Protein binding c. Concentration of free drug d. Lipid solubility e. Degree of ionization tissue pH f. Uteroplacental blood flow g. Placental surface area.  The rate of drug transfer across the placenta is increased in late pregnancy.
  • 21. This is due to: a. Increased unbound drug available for transfer b. Increased uteroplacental blood flow c. Increased placental surface area d. Decreased thickness of the placental membranes
  • 23. Keeping these in mind, the following guidelines are formulated: If the benefit outweighs the potential risks, only then can the particular drug be used with prior counseling Only, well tested and reputed drugs are to be prescribed and that too using the minimum therapeutic dosage for the shortest possible duration.
  • 24. ALCOHOl: Heavy drinkers (≥ 3 oz) have major risk to the fetus (6%). Fetal Alcohol Syndrome (FAS) is defined as the presence of at least one characteristic from each of the following three categories: 1. Growth restriction before and/or after birth. 2. Facial anomalies: Small palpebral fi ssures, indistinct or absent philtrum, epicanthic folds, fl attened nasal bridge, short length of nose, thin upper lip, low set and unparallel ears and retarded midfacial development. 3. CNS dysfunction: Microcephaly, mental retardation, abnormal neurobehavioral development (attention deficit with hyperactivity).
  • 25. PATERNALLY MEDICATED DRUGS AFFECTING HUMAN PREGNANCY: Adverse effects on human progeny has been observed in the form of abortion, congenital malformations, low birth weight and increased perinatal loss when the father has been exposed to lead, anesthetic agents, smoking or caffeine ingestion. These agents probably alter the morphology of the spermatozoa or cause some change in the composition of the semen.